Kamran Alam

2023 - Taysha Gene Therapies

In 2023, Kamran Alam earned a total compensation of $975.4K as Chief Financial Officer at Taysha Gene Therapies, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,950
Option Awards$402,039
Salary$413,751
Other$10,661
Total$975,401

Alam received $413.8K in salary, accounting for 42% of the total pay in 2023.

Alam also received $149K in non-equity incentive plan, $402K in option awards and $10.7K in other compensation.

Rankings

In 2023, Kamran Alam's compensation ranked 1,241st out of 2,978 executives tracked by ExecPay. In other words, Alam earned more than 58.3% of executives.

ClassificationRankingPercentile
All
1,241
out of 2,978
58th
Division
Manufacturing
734
out of 1,637
55th
Major group
Chemicals And Allied Products
490
out of 906
46th
Industry group
Drugs
478
out of 869
45th
Industry
Biological Products, Except Diagnostic Substances
138
out of 211
35th
Source: SEC filing on April 18, 2024.

Alam's colleagues

We found two more compensation records of executives who worked with Kamran Alam at Taysha Gene Therapies in 2023.

2023

Sean Nolan

Taysha Gene Therapies

Chief Executive Officer

2023

Sukumar Nagendran

Taysha Gene Therapies

President and Head of Research and Development

News

You may also like